We are delighted to learn that we are one of only 20 UK CBD companies to be officially recommended for use by the MCCS (Medical Cannabis Clinicians Society)
This is obviously fantastic news for us, and we are extremely proud of this prestigious accolade.
We work really hard to ensure premium, safe and effective CBD products, so to receive this recognition makes us really hapi!
It is now common for doctors to be asked about CBD products which are often favoured as the first port of call for medicinal cannabis, as purchasing over the counter products can be simpler, cheaper, and easier than a medical consultation and a prescription for medicinal cannabis. There is a plethora of products on the market (214 producers have been reviewed for this guide) and a bewildering array of choices that can make it difficult to choose one CBD product.
So, the MCCS has produced a “Clinicians Guide to CBD” which outlines the basic principles of CBD usage. This “Recommendations for Good CBD Oil” is a companion volume to the “Clinicians Guide” – www.ukmccs.org
This list was created by looking at the CBD Oil Content, Type, Dosage, Safety and Labelling of CBD retailers.
MCCS Co-Founder Professor Mike Barnes said –
“The new CBD: Recommendations for Good Practice guide contains recommendations for what the Society considers a good CBD product. The Society has over 300 members most of which are the UK prescribing cannabis doctors. Often our doctors are asked to advise on which CBD products could be tried for various medical conditions before the patient tries a prescribed medication. We anticipate that our doctors will recommend a product from this list. Sometimes an over-the-counter CBD product is sufficient to help the condition and is much cheaper.
I am pleased to say that hapihemp, has fulfilled all the criteria and is one of only 20 UK companies to have done so. “
All of our products are thoroughly tested, and we only work with the best manufacturers who have the same core values as us.
We only sell CBD products that we believe in… for example our CBD patches are 20mg of CBD per patch and last for at least 24 hours.
Our CBD body oil contains some amazing essential oils including Camphor as well as CBD, as we believe that essential oils and CBD are a powerful match made in heaven!
Find out more about the MCCS and the new CBD Recommendations for Good Practice guide below…
The Medical Cannabis Clinicians Society www.ukmccs.org gives clinicians the opportunity to share practical knowledge, develop transparent and independent guidance and lead the conversation as doctors in the sector.
As more and more doctors begin to prescribe medical cannabis for their patients, the Society provides a confidential, independent network for clinicians to share experiences in patient consultation, prescribing, accessing products and treatments, research, and evidence.
Members of the Society have access to further information including prescribing guidelines, a secure online support network and discounts on training and events.
The Medical Cannabis Clinicians Society is a community interest company: Medcan Clinicians Society CIC (company #12000732).
What is the purpose of this UK CBD guide?
Over the counter (OTC) CBD is now very popular and a multimillion-pound market. Many people use CBD for medical purposes even though the producers cannot make medical claims. It is now common for doctors to be asked about CBD products and these are often favoured as the first port of call for medicinal cannabis as purchasing an OTC product is simpler, easier, and cheaper than a medical consultation and prescription cannabis medicine. There is a plethora of products on the market (214 producers have been reviewed for this guide) and a bewildering array of choices. Which to choose, which to advise? The Medical Cannabis Clinicians Society have produced a “Clinicians Guide to CBD” which outlines the basic principles of CBD usage but avoided specific product discussion. This “Recommendations for Good CBD Oil” is a companion volume to the “Clinicians Guide”
What does this UK CBD guide cover?
What do doctors and the public want from a CBD product?
Certificate of Analysis
A readily accessible Certificate of Analysis (C of A) is essential. The C of A should tell the consumer what is in the product. It should state which cannabinoids are present, not just CBD but the amount of other “minor” cannabinoids, including the number of controlled cannabinoids, such as THC. The terpene profile is also important for the overall effect of the product.
The carrier oil is important as it can be the source of an allergic reaction. Thus, we believe that every product must state the carrier oil.
There must be clear labelling, so the consumer knows exactly what is in the bottle. The C of A should confirm that the labelling is correct. We prefer a label which states the mg/ml of the cannabinoids rather than a percentage concentration. We also think it is important that the consumer is aware of whether an oil is full spectrum (unlikely to be legal), broad spectrum or an isolate.
It is important that the consumer is appropriately warned about safety considerations. This should include a note that the product should not be used by children, not to be used during pregnancy or whilst breastfeeding and if the consumer is on any other medication, they should consult their doctor. This information ideally should be clear at the point of sale. However, whilst this is not compulsory from a statutory standpoint, we feel this is important information that should be given. We also feel that a doctor should be responsible for warning the patient about these issues.
We feel that products should state whether they are suitable for vegans and whether they are gluten-free.